Development of a Cellular Assay as a Personalized Model for Testing Chronic Wound Therapeutics

Petra Doerfler1, Nicole Schoefmann1, Gabriela Cabral1

  • 1Akribes Biomedical GmbH, Vienna, Austria.

Summary

Researchers developed a new assay using fibroblast proliferation to distinguish between healing and nonhealing chronic wounds. This functional biomarker assay accurately identifies wound healing status and therapeutic effectiveness ex vivo.

Related Concept Videos